arrow
T

Tanis C. Dingle

University of Calgary
H指数:25
被引数:3,758

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phylogenomic analysis and genetic mechanisms of antifungal resistance in clinical isolates of Candida glabrata (Nakaseomyces glabratus) from across Canada, 2013-2020

加拿大2013-2020年临床分离的克柔念珠菌(Nakaseomyces glabratus)的抗真菌耐药性系统发育基因组学分析及遗传机制

2025-11-010
PRE
Preparedness for Candida auris in Canadian Nosocomial Infection Surveillance Program (CNISP) hospitals, 2024
2025-10-010
OAAI
One Health study of mobile colistin resistance (mcr) in Salmonella enterica in Canada, 2017-2022

2017-2022年加拿大沙门氏菌属中可移动黏菌素耐药(mcr)的“同一健康”研究

2025-05-190
OA
Validation of a modified rapid test to detect the cefazolin inoculum effect in methicillin-susceptible Staphylococcus aureus from bloodstream infections in hospitals from North and Latin America
2025-03-010
PRE
Reply to Kidd et al., Inconsistencies within the proposed framework for stabilizing fungal nomenclature risk further confusion

对Kidd等人的答复,“稳定真菌命名风险的拟议框架内的不一致” 进一步混淆

2024-04-100
OA
A conceptual framework for nomenclatural stability and validity of medically important fungi: a proposed global consensus guideline for fungal name changes supported by ABP, ASM, CLSI, ECMM, ESCMID-EFISG, EUCAST-AFST, FDLC, IDSA, ISHAM, MMSA, and MSGERC
2023-11-2128
OAAI
A two-ward acute care hospital outbreak of SARS-CoV-2 delta variant including a point-source outbreak associated with the use of a mobile vital signs cart and sub-optimal doffing of personal protective equipment
2023-01-016
OAAI
Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021)

新型冠状病毒肺炎患者的抗菌素耐药性 (AMR): 系统评价和荟萃分析 (2019年11月2021年6月)

2022-03-07126
OAAI